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Introduction {#sec1}
============

Adult hippocampal neurogenesis is a highly orchestrated process with cells passing through distinct stages to generate granule cell neurons (GCNs) throughout life ([@bib4], [@bib29], [@bib43]). This process is initiated from neural stem cells (NSCs) in the subgranular zone (SGZ) that cycle between quiescence and an activated state in which they generate transiently amplifying precursors (TAPs) from which new post-mitotic neurones are formed via an intermediate neuroblast (NB) state. These newly formed neurons eventually integrate into the existing dentate gyrus granule cell network thereby creating new connections that contribute to CNS plasticity.

A link between hippocampal neurogenesis and cognitive function is well established and adult-onset hypothyroidism is known to result in cognitive perturbations, such as learning and memory deficits ([@bib10], [@bib39], [@bib42], [@bib43]). In light of this, a number of studies have investigated if TH deficiency impairs the hippocampal neurogenic process. These studies have consistently demonstrated an effect on progenitor differentiation and the generation of neurons, but no consistent effects earlier in the lineage on NSC behavior ([@bib1], [@bib12], [@bib40]). However, a key question that remains unanswered is whether this effect results from a cell-autonomous requirement for TH signaling within the hippocampal lineage or from an indirect, non-cell-autonomous effect resulting from TH function in supporting glial and other cell types. Addressing this is important to identify the necessary cellular targets for therapies designed to treat age-related cognitive decline based on modulated TH signaling.

One strategy to address this question is to identify essential components of the TH signaling pathway selectively expressed in NBs and then compare the effects of global and conditional knockouts of these components. The latter will reveal only cell-autonomous effects, while the former will reveal both cell- and non-cell-autonomous effects. By examining the cellular expression pattern of components of the TH signaling pathway throughout the adult hippocampal neurogenic program we identified such a component, the TH transporter monocarboxylate transporter 8 (MCT8). Transgenic mice lacking MCT8 either globally or just in the hippocampal neurogenic lineage both showed impaired differentiation of NBs and a reduced formation of new GCNs in the adult hippocampus. This impairment is associated with an improper regulation of the cell-cycle inhibitor P27KIP1 in neural progenitors. We conclude that the effect of TH on the generation of neurons from NBs is cell-autonomous and that MCT8 is a critical gate-keeper for this step of hippocampal neurogenesis.

Results {#sec2}
=======

Differential Expression of TH Signaling Components within the Hippocampal Neurogenic Lineage {#sec2.1}
--------------------------------------------------------------------------------------------

TH signaling in the CNS is regulated at several levels. First, TH transporters, such as the L-type amino acid transporters (LAT) 1 and 2, organic anion transporting polypeptide (OATP) 1C1, and MCT8 and MCT10, are mandatory for TH transmembrane passage across the blood-brain barrier (BBB) and cellular TH uptake ([@bib6], [@bib20]). Second, intracellular iodothyronine deiodinases (DIO) then either activate (DIO2) or inactivate (DIO3) TH ([@bib7]). Third, μ-Cristallin (CRYM), a cytosolic TH binding protein, can regulate intracellular TH levels ([@bib47]). Fourth, nuclear TH receptors (TRs) encompassing the ligand binding isoforms TRα1, TRβ1, and TRβ2, as well as non-ligand binding isoforms such as TRα2, regulate gene expression in response to TH ([@bib15], [@bib32]). Last, co-activators or co-repressors are recruited to TR isoforms, including NCOR (nuclear receptor corepressor; NCOR1) and SMRT (silencing mediator of retinoid and thyroid hormone receptors; NCOR2) ([@bib2]).

To unravel the temporal expression pattern of these TH signaling components in the adult mouse hippocampus and identify any selectively expressed in NBs, we micro-dissected and dissociated dentate gyri for fluorescence-activated cell sorting (FACS). We used intracellular markers to isolate different progenitor/neuronal populations that develop in sequence within the hippocampal neurogenic lineage ([@bib29]) ([Figure 1](#fig1){ref-type="fig"}A). The first cell population comprises NSCs that are located in the SGZ of the dentate gyrus, extend a radial process into the molecular layer, and are positive for glia fibrillary acidic protein (GFAP), SRY-Box 2 (SOX2), and NESTIN. The second population encompasses TAPs (intermediate progenitors; type 2a and type 2b progenitors), which express the transcription factor T-box brain protein 2 (TBR2) and are generated by asymmetrical division of activated NSCs. This population can be subdivided by expression of the neuronal differentiation-promoting factor PROX1 (prospero homeobox 1) and the immature neuronal marker doublecortin (DCX) in type 2b progenitors. Cells of the third population, DCX+ type 3 NBs, develop a vertical process while exiting the cell cycle to generate, fourth, immature post-mitotic neurons (INs), which are characterized by transient expression of the calcium-binding protein calretinin (CR). Finally, the fifth population comprises GCNs in which DCX and CR expression cease and calbindin (CB) expression is initiated.Figure 1Alterations in mRNA Expression of TH Signaling Components during Adult Hippocampal NeurogenesisMicro-dissected dentate gyri were subjected to FACS and neurogenic/neuronal populations were sorted according to their expression of intracellular markers.(A) Schematic representation of the hippocampal neurogenic program illustrating expression of stage-specific markers used for sorting and validation strategies.(B--E) (B) qPCR analysis of neurogenic markers showing that isolated populations are of the expected identity. Relative mRNA expression of (C) TH transporters, (D) TH receptor isoforms, and (E) accessory proteins are depicted. Transcript levels were normalized to *Gapdh* expression and transcript expression in GCN. Note that, due to their absence from GCN samples, *Hes5* and *Lat1* values were normalized to NSC levels while *Dcx* expression was normalized to NB values. n = 2--4 individual samples per cell population. Group means + SEM are shown.

Using forward and side scatter, we separated cells (P1; 2.1%--8.0%) from debris and selected single cells (P2; 94.9%--98.9%) ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Single cells viable before fixation were identified based on a low intensity of a fixable live/dead cell stain (P3; 38.4%--53.4%). From those cells, a TBR2+ population was isolated (0.6%--2.3%) ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The TBR2− population (P4) was then subdivided into a DCX− and a DCX+ population (4.1%--7.8%). The latter was then sorted into CR− NBs (51.1%--92.4%) and into CR+ INs (5.9%--42.6%). In a second sorting strategy, CB+ GCNs (5.5%--21.3%) were isolated from live cells (P3) ([Figure S1](#mmc1){ref-type="supplementary-material"}C). From the CB− population (P4) NESTIN+/GFAP+ NSCs were sorted (1.1%--5.2%). All other cells were collected for RIN (RNA integrity number) value determination. To preserve RNA integrity, we performed staining and sorting steps at low temperatures and in the presence of RNase inhibitor. As shown in [Figure S1](#mmc1){ref-type="supplementary-material"}D comparing the RIN value of a fixed sample, a fixed/stained sample and cells undergoing the staining/sorting procedure, a RIN value of 7.0 or higher was reached with our measures.

We then performed qPCR on isolated populations after mRNA amplification. To validate the identity of the isolated cell populations, neurogenic marker expression was analyzed ([Figure 1](#fig1){ref-type="fig"}B). The stem cell marker *Hes5* ([@bib4]) was strongly expressed in NSCs. As expected, we found high *Dcx* mRNA expression in TAPs, NBs, and INs. *Prox1* transcript was expressed in NB, IN, and GCN samples. *NeuN* mRNA, although detectable in TAP and NB, was highly enriched in GCN samples. NSC, NB, and GCN samples were also used for RT-PCR ([Figure S1](#mmc1){ref-type="supplementary-material"}E). *Dcx* was again enriched in the NB population, while the lineage marker *Prox1* was found in both NBs and GCNs.

Next, we assessed the mRNA expression profile of TH signaling components. Within the TH transporters ([Figure 1](#fig1){ref-type="fig"}C), we observed *Mct8* transcripts primarily in NBs and GCNs, while *Mct1*0 mRNA was enriched in mature neurons. *Lat1* and *Lat2* expression was detected in NSCs and TAPs, whereas only *Lat2* was further enriched in GCNs. Analysis of TR expression profiles revealed *Trα1*, *Trα2*, *Trβ1*, and *Trβ2* transcripts in the hippocampal lineage ([Figure 1](#fig1){ref-type="fig"}D). While both *Trα* isoforms and *Trβ1* mRNAs were predominantly expressed in NSC, NB, and GCN populations, *Trβ2* transcript levels were downregulated upon neuronal maturation. Finally, *Crym*, *Dio3*, *Ncor*, and *Smrt* exhibited a similar profile of transcripts with peaks in NB and GCN stages ([Figure 1](#fig1){ref-type="fig"}E), matching the expression of *Mct8*, *Trα1*, and *Trα2*. Of note, *Oatp1c1*, *Dio1*, and *Dio2* transcripts were not detected in the analyzed cell populations.

To complement our qPCR analysis, we performed immunofluorescence studies using perfusion-fixed brain cryosections from 2-month-old animals and commercially available antibodies against DIO3, LAT1, LAT2, MCT8, and MCT10 in combination with cell-type-specific markers ([Figure 2](#fig2){ref-type="fig"}). In contrast to our qPCR results, LAT1 co-localized only with the endothelial cell marker CD31/PECAM-1 throughout the dentate gyrus ([Figure S2](#mmc1){ref-type="supplementary-material"}), while none of the proteins above could be detected in GFAP+/SOX2+ NSCs ([Figure 2](#fig2){ref-type="fig"}A). No co-localization with the proliferation marker MCM2 present in activated NSCs, TAPs, and cycling NBs was observed for any component except MCT8, which was found in a specific subset of MCM2+ cells also expressing DCX ([Figure 2](#fig2){ref-type="fig"}B). By using a triple-staining protocol, we observed strong expression of MCT8 protein in DCX+/CR− NBs and in DCX+/CR+ INs ([Figure 2](#fig2){ref-type="fig"}A) while none of the other proteins showed detectable expression at this stage. In agreement with our qPCR results, CB+ GCNs were positive for DIO3, LAT2, MCT8, and MCT10 protein. Whereas MCT8 and MCT10 exhibited equal expression throughout the granule cell layer, an asymmetrical pattern was found for DIO3 and LAT2 with stronger signals in the region contacting the molecular layer of the hippocampus ([Figure 2](#fig2){ref-type="fig"}C). We conclude that MCT8 is present in NBs, while later stages of the lineage contain a wider range of transporters. As TH transporters are essential for TH signaling, this finding identifies MCT8 as a possible target for our global and conditional knockout strategy to define the cell autonomy of TH signaling during the generation of neurons from NBs.Figure 2Spatiotemporal Protein Expression of TH Signaling Components(A) Perfusion-fixed coronal forebrain cryosections were immunostained to visualize DIO3, LAT1, LAT2, MCT8, and MCT10 protein (green) in the SGZ in GFAP+ (magenta)/SOX2+ (blue) NSCs, in MCM2+ (magenta) proliferating cells, in DCX+ (magenta) cells either negative for CR (type 2b progenitors and NBs) or CR+ (blue; INs), and in CB+ (magenta) GCNs. Nuclei were stained with Hoechst 33258 (gray).(B) MCT8 (green) co-stained with MCM2 (blue) in DCX+ (magenta; arrowhead) but not DCX− (^∗^) cells. Cell nuclei counterstained by Hoechst 33258 are displayed in gray.(C) Distribution of DIO3, LAT2, MCT8, and MCT10 (green) over the height of the suprapyramidal blade of the dentate gyrus. Nuclei were stained for Hoechst 33258 (gray) and mature GCNs were identified by CB (magenta). DIO3 and LAT2 protein are asymmetrically distributed with higher signal intensities in areas close to the molecular layer, while MCT8 and MCT0 appear evenly dispersed.

Inhibition of MCT8 Reduces the Formation of New Neurons in Adult Hippocampal Slices {#sec2.2}
-----------------------------------------------------------------------------------

Before generating transgenic mice, we sought to confirm a functional role for MCT8 in hippocampal neurogenesis using commercially available inhibitors *in vitro*. For that purpose, we established a protocol to maintain adult hippocampal slices for at least 3 weeks by combining different published protocols ([@bib30], [@bib31]) and adding indomethacin for its protective effects on neurogenesis *in vivo* and *ex vivo* ([@bib18], [@bib38]). As a readout, we performed EdU-tracing studies together with KI67 labeling to quantify progenitor proliferation, DCX labeling to quantify type 2b progenitors, NBs, and INs, and NEUN staining for neurons ([Figure 3](#fig3){ref-type="fig"}A).Figure 3Inhibition of MCT8 in Adult Slices Perturbs Neuron FormationAfter acute EdU injection, adult brain slices cultured *ex vivo* for up to 3 weeks. Lineage progression in the presence of TH signaling inhibitors was assessed.(A) Exemplar pictures from adult slices grown in control medium. EdU incorporation (magenta) into proliferating cells (KI67+, green) was visualized after 1 day; into DCX+ cells (type 2b progenitors, NBs and INs) after 7 days; and into newly formed neurons (NEUN+, green) after 21 days. Hoechst 33258-counterstained nuclei are shown in blue. Total number of EdU+ cells (B) and incorporation of EdU into KI67+ cells (C) after 1 day in culture, EdU+/DCX+ cells at day 7 (D) and newly formed neurons (EdU+/NEUN+) at day 21 (E) upon exposure to 25 μM silychristin were quantified. n = 4--6 mice per condition. Group means + SEM are shown.∗, p \< 0.05, unpaired two-tailed Student's t test.

Incubation with the MCT8-specific inhibitor silychristin ([@bib25]) for 24 h did not alter proliferation in the SGZ ([Figure S3](#mmc1){ref-type="supplementary-material"}A) or the number of EdU+ and KI67+/EdU+ cells ([Figures 3](#fig3){ref-type="fig"}B and 3C). By 7 days in culture a trend toward decreased formation (EdU+, [Figure 3](#fig3){ref-type="fig"}D) and proliferation (KI67+/EdU+, [Figure S3](#mmc1){ref-type="supplementary-material"}A) of DCX+ cells in silychristin-treated slices was seen, while longer incubation with the inhibitor resulted in a significant reduction of newly formed neurons (NEUN+/EdU+) after 21 days ([Figure 3](#fig3){ref-type="fig"}E). By contrast, treatment of hippocampal slices with the LAT inhibitor BCH ([@bib44], [@bib45]) or the deiodinase inhibitor iopanoic acid ([@bib11]) had no effect on proliferation or NB and neuron formation ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). These inhibitor studies point to a crucial role of MCT8 during later stages of hippocampal neurogenesis.

Absence of MCT8 *In Vivo* Compromises Adult Hippocampal Neurogenesis {#sec2.3}
--------------------------------------------------------------------

Having confirmed a functional role for MCT8 *in vitro*, we assessed the consequences of global inactivation of MCT8 *in vivo*. At the age of 2 months, overall NSC numbers (defined as GFAP+/SOX2+ cells extending a radial process into the granule cell layer) were the same in MCT8 knockout (KO) and wild-type (WT) littermates. However, NSC activation was impaired in MCT8 KO mice as significantly fewer NSCs were labeled by the proliferation marker KI67 ([Figure 4](#fig4){ref-type="fig"}A). Total numbers of KI67+ progenitors and the density of KI67+/DCX+ type 2b and type 3 progenitors were similar between the genotypes ([Figure 4](#fig4){ref-type="fig"}B). Likewise, no difference in the number of TBR2+ TAPs ([Figure S4](#mmc1){ref-type="supplementary-material"}A), cleaved caspase-3+ apoptotic cells ([Figure S4](#mmc1){ref-type="supplementary-material"}B) and DCX+/CR− NBs ([Figure 4](#fig4){ref-type="fig"}C) could be observed. In contrast, a significantly reduced number of DCX+/CR+ INs was found in the MCT8 KO SGZ ([Figure 4](#fig4){ref-type="fig"}C) pointing to impaired differentiation.Figure 4Adult Hippocampal Neurogenesis Is Altered in 2-Month-Old MCT8 KO MicePerfusion-fixed cryosections of 2-month-old WT and MCT8 KO littermates were immunostained for stage-specific markers of hippocampal neurogenesis.(A) Total numbers of GFAP+ (cyan) and SOX2+ (yellow) NSCs (arrowheads) harboring a single process protruding into the granule cell layer, and activated NSCs (KI67+; magenta; arrows).(B) Overall numbers of proliferating cells in the SGZ (all KI67+ cells; green; arrowheads) and numbers of proliferating type 2b/NBs expressing KI67 and DCX (magenta; arrows).(C) DCX (magenta) and CR (green) were used to discriminate between type 2b progenitors/NBs (only DCX+; arrows) and INs (DCX+/CR+; arrowheads).(D) Timeline of EdU-labeling experiments. Injected at P60, mice were perfused 3 or 28 days later and stained as shown.(E) EdU (cyan) retention in proliferating progenitors (KI67+; yellow; arrowheads) and DCX+ (magenta; arrows) cells was assessed at 3 dpi.(F) Incorporation of EdU (cyan) into type 2b progenitors/NBs (DCX+ \[magenta\]/CR− \[yellow\]; arrows) and into INs (DCX+/CR+; arrowheads).(G) 28 days after EdU pulse, GCN formation (CB+ \[green\] and EdU \[magenta\]) was analyzed. In all experiments, cell nuclei were counterstained with Hoechst 33258 (blue). n = 4 (28 dp EdU) or n = 6 (3 dp EdU) mice per genotype. Group means + SEM are shown.∗, p \< 0.05; ∗∗, p \< 0.01, unpaired two-tailed Student's t test.

To explore the dynamics of neurogenesis further, we performed EdU label-retention studies. We injected 2-month-old mice with EdU and followed the formation of progenitor cells and neurons by NSCs in the hippocampus ([Figure 4](#fig4){ref-type="fig"}D) either at day 3 post injection (3 dpi) to examine the level of proliferation within each population or 28 dpi to quantify the number of labeled cells that are fully differentiated. At 3 dpi, we detected significantly more EdU-labeled KI67+/DCX+ progenitors and DCX+/CR− NBs in MCT8 KO mice compared with WT littermates ([Figures 4](#fig4){ref-type="fig"}E and 4F, respectively), whereas numbers of DCX+/CR+/EdU+ newly formed INs were not different ([Figure 4](#fig4){ref-type="fig"}F). At 28 dpi, significantly fewer EdU+/CB+ GCNs were seen in MCT8 KO mice ([Figure 4](#fig4){ref-type="fig"}G), demonstrating that dividing NBs exhibit differentiation impairments in the absence of MCT8.

Hippocampal neurogenesis is highly active in young animals and rapidly declines with age, being already greatly compromised at around 6 months of age ([@bib5], [@bib33]). We wondered if the deficits resulting from loss of MCT8 are also observed at older ages when the number of cells transitioning from NB to neuron populations is reduced. To address this, we repeated our analysis at 6 months using the same EdU injection paradigm as in [Figure 4](#fig4){ref-type="fig"}D. At this age, MCT8 KO mice exhibited a slight but significantly increased density of GFAP+/SOX2+ cells with a radial process in the SGZ, while similar numbers of NSCs were labeled with KI67 ([Figure 5](#fig5){ref-type="fig"}A). No differences were observed in the number of TBR2+ TAPs ([Figure S5](#mmc1){ref-type="supplementary-material"}A), cleaved caspase-3+ apoptotic cells ([Figure S5](#mmc1){ref-type="supplementary-material"}B), or the total number of KI67+ cells. Although the increase in KI67+/DCX+ cells did not reach statistical significance ([Figure 5](#fig5){ref-type="fig"}B), the number of DCX+/CR− cells in the SGZ (comprising NBs and type 2b cells) was almost doubled in MCT8 KO mice ([Figure 5](#fig5){ref-type="fig"}C). In contrast, MCT8 KO mice demonstrated a severely reduced formation of new GCNs (CB+/EdU+) when assessed at 28 dpi ([Figure 5](#fig5){ref-type="fig"}D). We conclude that the deficit in neuron differentiation is also present in older animals despite the overall reduction in neurogenesis.Figure 5MCT8 Deficiency Compromises Adult Hippocampal Neurogenesis at 6 Months of AgeNeurogenesis was assessed in 6-month-old males.(A) Numbers of GFAP+ (cyan)/SOX2+ (yellow) NSCs with a radial process (arrowheads) as well as density of activated KI67+ (magenta; arrow) NSCs.(B) Proliferation 3 days after EdU injection. Overall KI67+ (cyan; arrows) and KI67+/EdU+ (yellow) cell numbers are shown. Late-stage proliferating cells expressing DCX (magenta; arrowheads) show a higher proliferative capacity.(C) Density of DCX+ (magenta)/CR− (cyan) type 2b progenitors/NBs (arrowheads) as well as of DCX+/CR+ INs (arrows) with or without EdU (3 dpi; yellow).(D) Newly formed GCNs (arrowheads) positive for CB (green) and EdU (magenta) were visualized 28 days after EdU injection.(E) Breeding strategy to generate males harboring the WT or *Mct8* KO allele as well as *Nestin-CreERT2* and *Rfp* reporter transgenes. Animals were gavaged for 5 consecutive days at 4 weeks of age and perfused at 6 months of age.(F) Numbers of GFAP+ (cyan)/SOX2+ (yellow) NSCs (arrows) with a radial process and of RFP+ (in magenta; arrowheads) NSCs were counted and quantified as per mm and percentage of RFP+ cells.(G) RFP+ (magenta)/CB+ (green) GCNs (arrowheads) were counted and normalized to the number of RFP+ cells. Cell nuclei were stained with Hoechst 33258 (blue). n = 4 (28 dp EdU and *Nestin-Cre; Rfp* animals) or n = 6 (3 dp EdU injection) mice per genotype. Group means + SEM are shown.∗, p \< 0.05; ∗∗, p \< 0.01; ∗∗∗, p \< 0.001, unpaired two-tailed Student's t test.

As a second approach to follow the progeny of dividing NSCs, we used a stable labeling strategy by generating WT and MCT8 KO mice expressing a *Nestin-CreERT2* construct and a *tdTomato* reporter (hereafter *Rfp*) ([Figure 5](#fig5){ref-type="fig"}E). Following 5 consecutive days of tamoxifen treatment at the age of 4 weeks, mice were kept for 5 months before analysis, so matching the 6-month time point used in the EdU analysis above. A similar absolute number of NSCs was labeled in both genotypes, although their relative contribution to all RFP+ cells was significantly higher in MCT8 KO mice ([Figure 5](#fig5){ref-type="fig"}F). Despite this, and in agreement with our EdU incorporation studies, the relative number of NSC-derived RFP+/CB+ cells among all RFP+ cells was significantly reduced in MCT8 KO mice. Together, our experiments using different labeling techniques and ages confirm that the absence of MCT8 and thus the loss of TH transporter activity in NBs inhibits the generation of new GCNs in the dentate gyrus.

The Deficit in Neuron Formation Caused by MCT8 Loss Is Cell-Autonomous {#sec2.4}
----------------------------------------------------------------------

These deficits in neurogenesis may result from cell-autonomous effects of MCT8 deletion in hippocampal NBs. Alternatively, the well-described endocrine alterations after global loss of MCT8, such as high serum T3 and low serum T4 levels and/or impaired transport of T3 across the BBB, which in turn causes a mild central TH deficiency ([@bib8], [@bib48]), may impact NB differentiation and GCN formation. To distinguish between these possibilities, we generated a mouse model with specific deletion of MCT8 in the adult neurogenic lineage ([Figure 6](#fig6){ref-type="fig"}A). To this end, *Mct8*+/fl females were mated with males heterozygous for the *Nestin-CreERT2* allele and homozygous for a *tdTomato* reporter allele (hereafter *Rfp*) ([Figure 6](#fig6){ref-type="fig"}A). *Mct8+/y*, *Nestin-CreERT2/+*, *Rfp/+* (control), and *Mct8fl/y*, *Nestin-CreERT2/+*, *Rfp/+* (MCT8-NSC KO) mice were used (note that the *Mct8* gene is located on the X chromosome). Tamoxifen-induced Cre-activation at 1 month of age resulted in RFP expression and deletion of MCT8 in MCT8-NSC KO animals in adult NSCs and thus the neurogenic lineages only as confirmed by the loss of MCT8 expression in RFP+ neurons in MCT8-NSC KO mice ([Figure S6](#mmc1){ref-type="supplementary-material"}A). All analyses were performed 5 months later to match the 6-month time point of global MCT8 KO mice which showed GCN formation impairments and higher NB numbers. Again, we corrected our analysis for differences between individual animals by normalizing cell counts to the overall number of RFP+ cells. We found no differences in the percentage of RFP+ NSCs ([Figure 6](#fig6){ref-type="fig"}B), activated NSCs (GFAP+/RFP+/KI67+/radial process; [Figure 6](#fig6){ref-type="fig"}C), proliferating cells (KI67+/RFP+), proliferating type 2b cells/NBs (DCX+/KI67+/RFP+) ([Figure 6](#fig6){ref-type="fig"}D), TBR2+/RFP+ TAPs ([Figure S6](#mmc1){ref-type="supplementary-material"}B), and apoptotic cells (caspase-3+/RFP+; [Figure 6](#fig6){ref-type="fig"}E). In contrast to age-matched global MCT8 KO mice in which NB numbers were increased, we detected a similar number of NBs (DCX+/CR−/RFP+) in MCT8-NSC KO and controls at 6 months of age alongside a trend toward fewer INs (DCX+/CR+/RFP+) ([Figure 6](#fig6){ref-type="fig"}F). As in global MCT8 KO mice, however, the relative number of CB+/RFP+ GCNs was significantly decreased in MCT8-NSC KO ([Figure 6](#fig6){ref-type="fig"}G), confirming a cell-autonomous role of MCT8 within the hippocampal neurogenic lineage.Figure 6Absence of MCT8 in NSCs Compromises Adult Hippocampal Neurogenesis(A) *Mct8*fl/+ females were bred with males carrying *Nestin-CreERT2* and *Rfp* reporter alleles to generate *Mct8*+/y, *Nestin-CreERT2*, *Rfp* (control), and *Mct8fl*/y, *Nestin-CreERT2*, *Rfp* (MCT8-NSC KO) littermates. Tamoxifen was given for 5 consecutive days at 4 weeks of age and animals were perfused at 6 months of age.(B) Number of RFP+ (magenta)/GFAP+ (yellow)/SOX2+ (cyan) NSCs per mm SGZ and their percentage contribution to all RFP+ cells was determined.(C--F) Relative numbers of RFP+ (magenta; arrowheads)-labeled activated NSCs (KI67+ \[yellow\]/GFAP+ \[cyan\]) (C), proliferating cells (KI67+; cyan) and proliferating DCX+ (yellow) cells (D), apoptotic cells (caspase-3+; green) (E), DCX+ (cyan)/CR−(yellow) type 2b progenitors/NBs, and RFP+/DCX+/CR+ INs (arrows) (F).(G) Ratio of RFP+ (magenta)/CB+ (green) GCNs (arrowheads) over all RFP+ cells. Hoechst 33258-labeled cell nuclei are depicted in blue. n = 5 mice per genotype. Group means + SEM are shown.∗∗, p \< 0.01, unpaired two-tailed Student's t test.

Expression of the Cell-Cycle Inhibitor P27KIP1 Is Impaired in MCT8 Deficiency {#sec2.5}
-----------------------------------------------------------------------------

One mechanism by which TH induces differentiation is by suppression of the cell cycle ([@bib43]), with direct regulation of cell-cycle inhibitors, such as cyclin-dependent kinase inhibitor 1B (CDKN1B; P27KIP1) ([@bib17], [@bib21]). To examine this mechanism in the hippocampal neurogenic lineage, we quantified P27KIP1 levels in DCX+/CR− NBs and DCX+/CR+ INs in 2-month-old WT and MCT8 KO mice ([Figure 7](#fig7){ref-type="fig"}A). We discovered significantly reduced P27 fluorescence intensities in both cell populations in MCT8 KO animals and replicated this finding in both 6-month-old MCT8 KO mice ([Figure 7](#fig7){ref-type="fig"}B) and 6-month-old MCT8-NSC KO mice ([Figure 7](#fig7){ref-type="fig"}C). As the CIP/KIP family of cell-cycle/CDK inhibitors comprises two more members, P21CIP1/WAF1 (CDKN1A) and P57KIP2 (CDKN1C), we assessed their expression in 2- and 6-month-old WT and MCT8 KO mice, but failed to observe differences in P21 ([Figures 7](#fig7){ref-type="fig"}D and 7E, respectively) and P57 ([Figures 7](#fig7){ref-type="fig"}F and 7G, respectively) immunofluorescence levels. Likewise, *p27kip1/Dcx* transcript ratios were reduced in micro-dissected dentate gyri from 6-month-old MCT8 KO mice, while *p5*7 mRNA levels were not different ([Figure S7](#mmc1){ref-type="supplementary-material"}). In summary, our results show a specific decrease in P27KIP1 after loss of MCT8 in the hippocampal neurogenic lineage, which likely underlies the impaired differentiation capacities in MCT8 deficiency.Figure 7Cell-Cycle Inhibitor Expression Is Altered in MCT8 Deficiency(A) Representative overview images and magnified views of P27KIP1 (green) staining in DCX+ (magenta) type 2b progenitors/NBs and DCX+/CR+ (blue) INs at 2 months of age. Normalized nuclear P27 fluorescent signal intensities were quantified.(B) P27 immunoreactivity in type 2b progenitors/NBs and INs was measured at 6 months of age.(C) Sections from 6-month-old MCT8-NSC KO and control brains were stained for P27KIP1 (green), DCX (blue), and CR (gray). RFP fluorescence is shown in magenta. Magnified views depict CR−/RFP+/DCX+ cells. Normalized P27 signal intensities were compared.(D and E) P21 (green) was analyzed at 2 months (D) and 6 months of age (E).(F and G) P57 (green) fluorescence intensities were assessed at 2 months (F) and 6 months (G) of age. Hoechst 33258-positive nuclei are shown in gray, DCX in magenta, and CR in blue. n = 6 (A, B, and D--G) and n = 4--5 (C) mice per genotype. Group means + SEM are shown.∗, p \< 0.05; ∗∗, p \< 0.01; ∗∗∗, p \< 0.001, unpaired two-tailed Student's t test.

Discussion {#sec3}
==========

Patients with adult-onset hypothyroidism show specific defects in hippocampal memory function and a decreased hippocampal volume ([@bib9], [@bib10], [@bib24]). These clinical findings may be explained by a profound impact of TH on hippocampal neurogenesis, a process imperative for learning and memory, as animal experiments have confirmed that TH deficiency delays neuronal differentiation and perturbs the birth of new GCN in the adult hippocampus ([@bib1], [@bib12], [@bib40]). However, the widespread systemic effects of TH deficiency make it impossible from these experiments using globally hypothyroid animals to resolve the key question if TH signaling impairs NB differentiation cell-autonomously. Here, we demonstrate such a cell-autonomous effect by using a conditional knockout strategy following a comprehensive analysis of the cell-specific repertoire of TH transporters, receptors, and metabolizing enzymes during hippocampal neurogenesis. A combination of FACS and qPCR allowed us to analyze distinct cell populations within the neurogenic program. With this approach, we could confirm the presence of *Trα*, *Trβ1*, and *Trβ2* transcripts in cycling progenitors and GCNs as well as *Trα1* expression in DCX+ progenitors as described before ([@bib12], [@bib28]). We also demonstrated the presence of DIO3 and the TH transporters LAT2, MCT8, and MCT10 in GCNs. Critically, however, of all TH transporters analyzed only MCT8 was found to be expressed in NBs at both the mRNA and protein level, suggesting a distinct function within the TH-regulated neurogenic program and enabling its manipulation as a means of addressing the central question of this study.

To our knowledge, this is the first study using a conditional knockout strategy to investigate TH signaling in the hippocampal lineage. The importance of this approach is highlighted by a comparison with a global MCT8 KO mouse model. The critical role of MCT8 in transporting T3 and T4 across brain barriers ([@bib6], [@bib8], [@bib48]) means that the brain of global MCT8 KO mice is in a mild hypothyroid state, affecting TH metabolism and regulation of TH target genes. That this causes non-cell-autonomous effects on neurogenesis is shown by our finding that at 6 months of age, the number of NBs was not altered in MCT8-NSC KO mice while it was increased in global MCT8 KO mice. This increase cannot simply be explained by a hypothyroid neurogenic niche due to a global loss of MCT8. Both TRα1 mutant mice that show features of a hypothyroid CNS and globally hypothyroid animals exhibit a reduced number of DCX+ cells in the SGZ ([@bib28], [@bib40]), while an increase in NB numbers was reported in TRα1 KO, hyperthyroid TRβKO, or T3-treated mice ([@bib28], [@bib27], [@bib26]). In the latter model, increased BrdU labeling of DCX+ cells was attributed to earlier acquisition of DCX immunoreactivity ([@bib26]). The increased EdU labeling in DCX+ cells we observe in MCT8 KO animals may be explained in the same way, linked to the hyperthyroid periphery of MCT8 KO mice ([@bib48]). In keeping with this, we do not see earlier DCX expression in slices treated with an MCT8 inhibitor, where the level of TH in the culture medium is normal. However, alterations in cell-cycle entry or kinetics cannot be fully excluded.

Non-cell-autonomous effects earlier in the lineage may also explain the differences observed in NSC and NB numbers at 2 and 6 months between MCT8 KO and WT animals. Reduced NSC activation in the global KO at 2 months (which as it is not seen in the MCT8-NSC KO mice must be a non-cell-autonomous effect of TH signaling) would be expected to preserve the NSC population and so explain the increased NSCs present in the MCT8 KO at 6 months as compared with WT mice at the same age. This in turn could attenuate the normal age-related decline in NBs (as would the earlier DCX expression discussed above), so explaining the smaller reduction in NBs at 6 months in these mice. Clearly, any of the neighboring glial and vascular cell types could contribute to this non-cell-autonomous effect. We hypothesize, however, that MCT8-deficient astrocytes contribute significantly through the previously described effects on TH-regulated components of the NOTCH or WNT signaling pathways ([@bib41]).

The role of MCT8 at the differentiation stage of neurogenesis is of particular relevance to the pathophysiology of Allan-Herndon-Dudley syndrome (AHDS), a severe form of psychomotor retardation caused by inactivating mutations in MCT8 ([@bib14], [@bib16], [@bib46]). AHDS-like symptoms could be replicated only by simultaneous inactivation of MCT8 and another TH transporter, OATP1C1, in mice ([@bib36]), from which we presumed that impaired TH transport across the BBB and/or BCSFB is the major abnormality driving the disease phenotype. Our results that MCT8 loss results in cell-autonomous effects in NBs, however, suggests that a direct effect on the formation of newly born GCNs may also contribute to the phenotype.

MCT8 has recently been implicated in corticogenesis in the chicken optic tectum ([@bib49]), where knockdown resulted in a reduced progenitor pool and diminished neurogenesis. Although we also observed reduced neurogenesis we found, in contrast to Vancamp et al., that MCT8 was critical for later stages of the adult hippocampal program in the mouse, i.e., the differentiation step from NBs to INs, and not for the regulation of progenitor proliferation and pool size. This emphasizes that the mechanisms by which TH signaling influences neurogenic processes vary between niches. Similarly, a different function of the TH signal is documented in a third niche, the adult SVZ, where, in contrast to the SGZ T3/TRα1, signaling is involved in repressing NSC pluripotency and determining the progenitor pool size ([@bib43]).

The organotypic hippocampal slice culture system that we established is likely to have significant utility. Our protocol that allows adult slices to be maintained for up to 3 weeks enables examination of all stages of adult neurogenesis and cell-fate monitoring of EdU+ cells. We used the technique to show that application of the MCT8-specific inhibitor silychristin compromised generation of EdU+/NEUN+ neurons after 3 weeks in culture without effects on EdU incorporation at earlier stages. This is in line with earlier *in vivo* studies of hypothyroid rodents that reported either no effect or only a slightly reduced progenitor proliferation of in the SGZ, whereas formation of new neurons was impaired ([@bib1], [@bib12], [@bib40]). In comparison, application of the LAT inhibitor BCH or the deiodinase inhibitor iopanoic acid did not alter neurogenesis in hippocampal slices. These findings underscore a prominent gate-keeper role of MCT8 in NBs and substantiate the view that, in the SGZ, TH predominantly acts on post-mitotic progenitors ([@bib43]).

To define a mechanism by which MCT8 in NBs is required for proper differentiation we investigated the expression of cell-cycle/CDK inhibitors P21CIP1, P27KIP1, and P57KIP2. In line with recent work ([@bib22]) we found pronounced P27 expression in SGZ NBs and INs of WT mice, whereas significantly lower P27 protein and mRNA levels were detected in MCT8 KO and MCT8-NSC KO mice. Based on that and reports showing *p27* as a TH target gene ([@bib17], [@bib21]), we speculate that absence of MCT8 in NBs causes TH deficiency within the cells, which in turn reduces the expression of P27 and inhibits differentiation. Consistent with this, P27-deficient mice have more proliferating cells in the SGZ, reduced levels of neurogenesis, and specific cognitive impairments ([@bib22]).

Our demonstration that, in the CNS, loss of MCT8 causes both cell-autonomous and non-cell-autonomous effects on neurogenesis will inform potential treatment strategies for AHDS where, in addition to any transport impairments across the BBB, effects of MCT8 loss in CNS cell populations will need to be addressed. Our findings also have important implications for therapeutic approaches addressing cognitive decline resulting from compromised hippocampal neurogenesis, where selective targeting of the cell-autonomous functions of TH signaling may allow enhanced neuronal differentiation without the systemic effects of increased TH action.

Experimental Procedures {#sec4}
=======================

Animals {#sec4.1}
-------

MCT8 KO mice obtained from Deltagen were generated, bred, and genotyped as described previously ([@bib48]). *Mct8*fl mice obtained from the KOMP repository (*Slc16a2*^*tm1a(KOMP)Wtsi*^) were generated and genotyped as reported before ([@bib37]). *Mct8*+/ KO and *Mct8*+/fl females were bred with males (C57BL/6) carrying a tamoxifen-inducible Cre recombinase driven by the *Nestin* promoter ([@bib34]) and a *Cre* reporter allele consisting of a *loxP*-flanked STOP cassette preventing transcription of a CAG promotor-driven *tdTomato* construct ([@bib35]) purchased from Jackson Laboratories (*C5*7BL/6-Tg*\[Nes-cre/ERT2\]KEisc/J*, Jax stock no. 016261 and *B6.Cg-Gt(ROSA)26Sor*^*tm9(CAG-tdTomato)Hze*^, Jax stock no. 007909). *Cre* and *tdTomato* (hereafter *Rfp*) transgenes were detected as described ([@bib34], [@bib35]). At the age of 4--5 weeks, tamoxifen (180 mg/kg; Sigma-Aldrich) was administered to *Mct8*+/y, *Mct8* KO/y, and *Mct8*fl/y male mice (note that the *Mct8* gene is located on the X chromosome) harboring both transgenes by oral gavage for 5 consecutive days and animals were kept for 5 months. For EdU-labeling studies, mice (aged 2 or 6 months) were injected intraperitoneally with 100 μL EdU (10 mg/mL; Thermo Fisher Scientific) in PBS 3 or 28 days before sacrifice. Six- to 8-week-old mice for hippocampal slice cultures were injected twice with EdU as above 4 and 2 h before sacrifice.

Mice were kept at constant temperature (22°C) on a 12-h light/dark cycle and provided with standard chow and water *ad libitum*. Animals used for FACS studies were sacrificed by cervical dislocation at 2 months of age. For immunofluorescence studies mice were transcardially perfused with 4% paraformaldehyde (PFA). Brains were cryo-protected with 30% sucrose, snap frozen in isopentane on dry ice and kept at −80°C. Mice designated for hippocampal slice culture were exposed to rising concentrations of CO~2~ and brains were isolated rapidly. For all studies, male mice have been used.

FACS {#sec4.2}
----

For one run, brains of eight C57BL/6N WT mice were isolated, stored in chilled Hibernate A (Thermo Fisher Scientific), and dentate gyri were micro-dissected ([@bib3]). Tissue was pooled and processed as described ([@bib19]) and as summarized in the [Supplemental Information](#app1){ref-type="fn"}.

Before fixation, cells were re-suspended in Hibernate A, incubated for 15 min with a fixable live/dead cell stain (LIVE/DEAD Fixable Violet Dead Cell Stain Kit; Life Technologies, 1:1,000) at 4°C and pelleted by centrifugation at 4,000 rpm for 4 min. For fixation, cells were re-suspended in 1 mL chilled Hibernate A, 3 mL of ice-cold 100% ethanol (molecular grade; Sigma-Aldrich) was added, and cells were fixed in this 75% ethanol solution at 4°C for 20 min ([@bib13]). To increase mRNA yield and quality, all solutions used after this step were treated overnight with 1:1,000 diethyl pyrocarbonate (Sigma-Aldrich) ([@bib13]). After fixation, cells were pelleted as above and washed in 1 mL chilled PBS containing 0.1% saponin (Sigma-Aldrich), 0.2% BSA (Sigma-Aldrich), and 1:100 RNase inhibitor (RNaseOUT, Life Technologies) ([@bib23]). Staining procedures are detailed in the [Supplemental Information](#app1){ref-type="fn"}.

Hippocampal neurogenic populations were sorted with a FACSAria II (BD Bioscience) into chilled RNase-free tubes containing 100 μL FACS buffer. All marker-negative cells were collected separately for RNA quality determination. If the final volume per tube exceeded 300 μL, cells were pelleted by centrifugation for 10 min at 13,200 rpm and 4°C. Cells were frozen on dry ice and stored at −80°C.

Adult Hippocampal Slice Culture {#sec4.3}
-------------------------------

Mouse brains were isolated and transferred into chilled dissection buffer (Hibernate A with 2% B27 supplement \[Life Technologies\], 2 mM L-glutamine and 1% penicillin/streptomycin) on ice as described ([@bib30]). Tissue was sectioned as published previously ([@bib31]) in chilled dissection buffer using a vibratome. Sections (300 μm) were stored in dissection buffer on ice and transferred onto Millicell inserts (Millipore). Organotypic slices were cultured at 37°C and 5% CO~2~ in a serum-free medium ([@bib30]) (Neurobasal A \[Life Technologies\] containing 2% B27 supplement, 2 mM L-glutamine, 1% penicillin/streptomycin, and 80 μM indomethacin \[Sigma-Aldrich\]). During the entire culture period slices were exposed to 25 μM silychristin (Sigma-Aldrich), 10 μM iopanoic acid (Sigma-Aldrich), 1 mM BCH (R&D Systems), or respective volumes of the solvents DMSO or culture medium as control. Culture medium was replaced every other day and slices were fixed for 1 h in 4% PFA.

Immunofluorescence Studies, Quantification, and RT-PCR {#sec4.4}
------------------------------------------------------

Procedures are described in the [Supplemental Information](#app1){ref-type="fn"}.

qPCR {#sec4.5}
----

Total RNA from FAC-sorted hippocampal populations and respective controls was isolated using the RNEasy Micro Kit (QIAGEN). RNA quality was assessed in controls on a high sensitivity screen tape (Agilent Technologies). At least 100,000 cells from control sorts were subjected to RIN value assessment. Samples were only processed further if RIN ≥ 7. Two rounds of RNA amplification were conducted using the ExpressArt C&E PICO RNA Amplification Kit (AMS Biotechnology) following the manufacturer\'s instructions. RNA concentration was analyzed with an RNA screentape (Agilent Technologies). If necessary, a third round of RNA amplification was performed and quantity was measured as before. A total of 250 ng of RNA was subjected to cDNA synthesis using the SuperScript First-Strand Synthesis System (Invitrogen). Quantitative Real-Time PCR (qPCR) was performed using the QuantiFast SYBR Green PCR Kit (QIAGEN) and the LightCycler 480 system (Roche). Further information can be found in the [Supplemental Information](#app1){ref-type="fn"} material.

Statistics {#sec4.6}
----------

All data represent mean + SEM. In slice culture experiments, to compare WT versus MCT8 KO animals and control versus MCT8-NSC KO mice statistical significance between groups was determined by unpaired two-tailed Student\'s t test. Differences were considered significant when p \< 0.05 and marked as follows ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

Study Approval {#sec4.7}
--------------

All studies were executed in compliance with UK Home Office regulations and local guidelines by The University of Edinburgh.
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